ITTO20110641A1 - Composizioni farmaceutiche e metodi di trattamento - Google Patents

Composizioni farmaceutiche e metodi di trattamento

Info

Publication number
ITTO20110641A1
ITTO20110641A1 IT000641A ITTO20110641A ITTO20110641A1 IT TO20110641 A1 ITTO20110641 A1 IT TO20110641A1 IT 000641 A IT000641 A IT 000641A IT TO20110641 A ITTO20110641 A IT TO20110641A IT TO20110641 A1 ITTO20110641 A1 IT TO20110641A1
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
treatment methods
treatment
methods
pharmaceutical
Prior art date
Application number
IT000641A
Other languages
English (en)
Inventor
Liudmila Fyodorovna Dolgovyh
Julia Leonidovna Dugina
Oleg Iliich Epshtein
Irina Anatolievna Kheyfets
Svetlana Alexandrovna Sergeeva
Sergey Alexandrovich Tarasov
Julia Alexandrovna Zabolotneva
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44899164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITTO20110641(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010129289/15A external-priority patent/RU2552221C2/ru
Priority claimed from RU2010130350/15A external-priority patent/RU2533224C2/ru
Priority claimed from RU2011122407A external-priority patent/RU2610438C2/ru
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Publication of ITTO20110641A1 publication Critical patent/ITTO20110641A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
IT000641A 2010-07-15 2011-07-15 Composizioni farmaceutiche e metodi di trattamento ITTO20110641A1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2010129289/15A RU2552221C2 (ru) 2010-07-15 2010-07-15 Способ лечения ожирения и сопутствующих метаболических расстройств и лекарственное средство для лечения ожирения и сопутствующих метаболических расстройств
RU2010130350/15A RU2533224C2 (ru) 2010-07-21 2010-07-21 Способ лечения зависимости от психоактивных веществ, алкоголизма и табакокурения и лекарственное средство для лечения зависимости от психоактивных веществ, алкоголизма и табакокурения
RU2011122407A RU2610438C2 (ru) 2011-06-02 2011-06-02 Способ лечения патологического синдрома и лекарственное средство центрального и периферического действия для лечения патологического синдрома

Publications (1)

Publication Number Publication Date
ITTO20110641A1 true ITTO20110641A1 (it) 2012-01-16

Family

ID=44899164

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000641A ITTO20110641A1 (it) 2010-07-15 2011-07-15 Composizioni farmaceutiche e metodi di trattamento

Country Status (29)

Country Link
US (1) US8865163B2 (it)
EP (1) EP2593477A2 (it)
JP (1) JP2013535436A (it)
KR (1) KR20140012009A (it)
CN (1) CN103124742A (it)
AR (1) AR082246A1 (it)
AU (1) AU2011278040B2 (it)
BR (1) BR112013000841A2 (it)
CA (1) CA2805091A1 (it)
CL (1) CL2013000098A1 (it)
CZ (1) CZ2013104A3 (it)
DE (1) DE112011102349T5 (it)
DK (1) DK201370078A (it)
EA (1) EA029400B1 (it)
EE (1) EE05760B1 (it)
ES (1) ES2542042R1 (it)
FI (1) FI20135146L (it)
FR (1) FR2962653A1 (it)
GB (1) GB2496076B (it)
IT (1) ITTO20110641A1 (it)
LT (1) LT5987B (it)
MX (1) MX361778B (it)
MY (1) MY158183A (it)
NO (1) NO20130219A1 (it)
NZ (1) NZ606768A (it)
PE (1) PE20131338A1 (it)
SE (1) SE1350179A1 (it)
SG (1) SG187037A1 (it)
WO (1) WO2012007847A2 (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
PE20130398A1 (es) 2010-07-15 2013-04-10 Oleg Iliich Epshtein Un metodo para aumentar el efecto de una forma activa potenciada de un anticuerpo
ES2425314R1 (es) * 2010-07-15 2014-07-09 Oleg Iliich Epshtein Composición farmacéutica combinada y uso para preparar medicamentos destinados al tratamiento de trastornos del sistema genitourinario
EP2593474A2 (en) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
WO2012010974A2 (en) * 2010-07-21 2012-01-26 Oleg Lliich Epshtein Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
ITTO20110632A1 (it) 2010-07-21 2012-01-22 Oleg Iliich Epshtein Metodo per trattare il disturbo da deficit di attenzione e iperattivita'
US8617555B2 (en) * 2010-07-21 2013-12-31 Oleg I. Epshtein Pharmaceutical compositions comprising activated-potentiated antibodies to human insulin receptor and endothelial nitric oxide (NO) synthase
JP2013533269A (ja) * 2010-07-21 2013-08-22 イリイチ・エプシテイン オレグ 組み合わせ医薬組成物及び呼吸器の疾患又は状態に関連する疾患及び状態を治療する方法
SG187732A1 (en) * 2010-08-06 2013-03-28 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
RU2013111961A (ru) * 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111962A (ru) * 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
EP4159761A1 (en) * 2014-03-27 2023-04-05 Bird Rock Bio, Inc. Antibodies that bind human cannabinoid 1 (cb1) receptor
CN104524568B (zh) * 2015-01-08 2018-04-20 中国人民解放军第二军医大学 一种治疗肥胖症的药物组合物及其应用
RU2727018C1 (ru) 2015-09-30 2020-07-17 Берд Рок Байо, Инк. Антитела, способные связываться с человеческим каннабиноидным рецептором 1 (cb1)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
BR9707418A (pt) 1996-02-12 1999-05-25 Oleg Iliich Epshtein Preparação medicinal e um método de ação medicinal sobre o organismo humano
US5849528A (en) 1997-08-21 1998-12-15 Incyte Pharmaceuticals, Inc.. Polynucleotides encoding a human S100 protein
RU2156621C1 (ru) 1999-03-04 2000-09-27 Эпштейн Олег Ильич Нейротропное лекарственное средство
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2209084C1 (ru) * 2001-12-26 2003-07-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения депрессивных расстройств
RU2201255C1 (ru) 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
US7229648B2 (en) 2003-03-14 2007-06-12 Dreyer Lee R Homeopathic formulations useful for treating pain and/or inflammation
US20050100513A1 (en) * 2003-11-10 2005-05-12 Watkins Mary B. Homeopathic method and system for treating nicotine addiction
EP1574211A1 (en) * 2004-03-09 2005-09-14 Inserm Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
KR20090024241A (ko) * 2006-06-06 2009-03-06 올레그 일리치 엡쉬테인 비만, 당뇨병 및 내당능 장애 관련 질병 치료용 약제
RU2438707C2 (ru) * 2006-06-06 2012-01-10 Олег Ильич Эпштейн Лекарственное средство для перорального лечения сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе, и способ получения твердой лекарственной формы для пероральной терапии сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе
RU2437678C2 (ru) 2006-06-06 2011-12-27 Олег Ильич Эпштейн Лекарственное средство для перорального лечения ожирения и способ получения твердой лекарственной формы для пероральной терапии ожирения
PE20080926A1 (es) * 2006-10-23 2008-07-19 Lilly Co Eli Compuestos cb1
EP1985295A1 (en) * 2007-04-04 2008-10-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
JP2010132631A (ja) * 2008-11-04 2010-06-17 Bizen Chemical Co Ltd カンナビノイド受容体のインバースアゴニストおよびアンタゴニスト活性を有する組成物
CA2804964C (en) 2010-07-15 2016-06-28 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
EP2593474A2 (en) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
ITTO20110634A1 (it) 2010-07-21 2012-01-22 Oleg Iliich Epshtein Metodo per trattare patologie organiche del sistema nervoso, la sindrome psicoorganica e l'encefalopatia
ITTO20110632A1 (it) 2010-07-21 2012-01-22 Oleg Iliich Epshtein Metodo per trattare il disturbo da deficit di attenzione e iperattivita'
WO2012010974A2 (en) 2010-07-21 2012-01-26 Oleg Lliich Epshtein Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
MX2013000808A (es) 2010-07-21 2013-10-28 Oleg Iliich Epshtein Un metodo para el tratamiento de la enfermedad de alzheimer.
US8617555B2 (en) 2010-07-21 2013-12-31 Oleg I. Epshtein Pharmaceutical compositions comprising activated-potentiated antibodies to human insulin receptor and endothelial nitric oxide (NO) synthase

Also Published As

Publication number Publication date
FI20135146L (fi) 2013-02-15
LT2013015A (lt) 2013-11-25
CA2805091A1 (en) 2012-01-19
AU2011278040A1 (en) 2013-03-07
KR20140012009A (ko) 2014-01-29
US8865163B2 (en) 2014-10-21
GB2496076A (en) 2013-05-01
LT5987B (lt) 2014-01-27
AU2011278040B2 (en) 2016-06-02
WO2012007847A2 (en) 2012-01-19
NO20130219A1 (no) 2013-03-22
ES2542042R1 (es) 2015-10-06
CN103124742A (zh) 2013-05-29
BR112013000841A2 (pt) 2016-06-07
ES2542042A2 (es) 2015-07-29
CL2013000098A1 (es) 2015-01-16
PE20131338A1 (es) 2013-11-18
MX361778B (es) 2018-12-17
EA201300133A1 (ru) 2014-03-31
EE05760B1 (et) 2016-03-15
EE201300005A (et) 2013-08-15
MY158183A (en) 2016-09-15
FR2962653A1 (fr) 2012-01-20
US20130017202A1 (en) 2013-01-17
NZ606768A (en) 2015-08-28
EA029400B1 (ru) 2018-03-30
AR082246A1 (es) 2012-11-21
EP2593477A2 (en) 2013-05-22
WO2012007847A3 (en) 2012-04-12
SG187037A1 (en) 2013-02-28
SE1350179A1 (sv) 2013-04-12
DK201370078A (en) 2013-02-14
GB2496076B (en) 2018-05-09
GB201302653D0 (en) 2013-04-03
JP2013535436A (ja) 2013-09-12
MX2013000545A (es) 2013-10-28
DE112011102349T5 (de) 2013-04-18
CZ2013104A3 (cs) 2013-05-29

Similar Documents

Publication Publication Date Title
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
SMT201700008B (it) Composizione farmaceutica
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
SMT201600350B (it) Composizioni farmaceutiche
SMT201600049B (it) Formulazioni di apixaban
DK3246018T3 (da) Farmaceutisk sammensætning
BRPI1011587A2 (pt) compostos e composições terapèuticas
BR112012018947A2 (pt) composição farmacêutica para tratamento e\ou prevenção do cancêr
SMT201400069B (it) Formulazione farmaceutica
BR112013014644A2 (pt) composição farmacêutica e complexo
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre
GT201200303A (es) Formulaciones farmacéuticas
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
SMT201600059B (it) Trattamento di infezioni da streptococco
CO6801722A2 (es) Composiciones farmacéuticas
BR112013008074A2 (pt) combinações farmacêuticas
ZA201402820B (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
SMT201500005B (it) Composizione framaceutica inalabile
EP2775831A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
BR112013014915A2 (pt) composição curativa e métodos de tratamento
DK3156060T3 (da) Farmaceutiske sammensætninger og topisk anvendelse deraf
BR112013003275A2 (pt) composição de tratamento oral
SMT201600243B (it) Composizioni farmaceutiche comprendenti anakinra senza citrato
BR112015002646A2 (pt) composto e composição farmacêutica
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina